To predict arrhythmic risk in carriers of filamin C truncating variants, a novel risk predictive model was developed based on ...

Life expectancy plummeted during the pandemic, with COVID-19 deaths, heart disease, and substance abuse playing major roles.

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

A positive patient-doctor relationship is an ingredient to a healthy life, and new research has zeroed in on the impact ...

Ballad Health Cardiovascular Summit has a new location but will continue to provide valuable insights into the latest advancements in diagnosing, treating and managing cardiovascular disease.

Recent research suggests that select athletes with cardiovascular abnormalities may be able to safely participate in competitive sports after shared decision-making with their clinicians about ...

Dr. Patel is an interventional cardiologist with expertise in complex coronary and peripheral interventions, according to a Feb. 20 news release from the organization.

Shared decision-making between clinicians and athletes of all ages who have cardiovascular abnormalities and want to participate in competitive sports is essential, according to a new joint scientific ...

One of the biggest challenges in managing AAA and PAD is the unpredictability of disease progression. For instance, while ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

This is part three of a three-part Healio Exclusive series on maternal and cardiovascular outcomes among Indigenous women ...

This year, rolling out had the privilege of attending Morehouse School of Medicine’s 50th-anniversary Men’s Health Breakfast, ...